1 stories
AI briefings + tags; source links are the ground truth.
About
🇨🇳
China
South China Morning Post
National & Local
China biotech outlicensing tops US$52 billion in first 2 months after global deal surge
In the first two months of the year, China's biotech outlicensing has exceeded US$52 billion, driven by significant partnerships with multinational pharmaceutical companies.
Mar 4 • 09:30 UTC